ClinConnect ClinConnect Logo
Search / Trial NCT06892795

Constructing a Risk Prediction Model for Intraoperative Hypothermia in Children Under General Anesthesia

Launched by HARBIN MEDICAL UNIVERSITY · Mar 22, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

The study first clarified the overall incidence and influencing factors of IOH in children through meta-analysis, combined with expert consultation to determine potential predictive variables, and developed a data questionnaire for this study. The second part of the study will collect data prospectively, use four algorithms in machine learning, including logistic regression, decision tree, random forest, and support vector machine, to build an excellent intraoperative hypothermia risk prediction model, and conduct internal verification of the model. The third part of the study prospectively...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \< 16 years old;
  • Anesthesia includes general anesthesia;
  • Anesthesia duration \> 30 minutes.
  • Exclusion Criteria:
  • Cardiac surgery or other procedures that require lowering the child's body temperature;
  • Refusing to participate in this study;
  • ASA grade \>Ⅳ;
  • Abnormal basal body temperature, preoperative core body temperature \<36.0℃ or \>38.0℃;
  • Hyperthyroidism or hypothyroidism and other diseases that affect body temperature;
  • The core body temperature cannot be measured due to surgery or ear canal disease.

About Harbin Medical University

Harbin Medical University is a prominent research institution located in Harbin, China, dedicated to advancing healthcare through innovative medical education and clinical research. With a strong emphasis on interdisciplinary collaboration, the university fosters a rigorous academic environment that supports a diverse range of clinical trials aimed at improving patient outcomes and addressing pressing health challenges. Its commitment to scientific excellence and ethical standards positions Harbin Medical University as a key player in the global medical research landscape, contributing valuable insights and breakthroughs in various fields of medicine.

Locations

Harbin, Heilongjiang, China

Patients applied

0 patients applied

Trial Officials

Huanglu Lan

Principal Investigator

The Sixth Affiliated Hospital of Harbin Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported